参考文献/References:
[1] 刘海波,许建秦,李春梦,等.胱抑素C和甘油三酯检测对糖尿病肾病的早期诊断价值研究[J].陕西医学杂志,2021,50(1):96-99.
[2] 屈雅娟,张敬芳,孙 旗,等.灯盏细辛联合依帕司他对糖尿病肾病模型大鼠的治疗作用及机制[J].陕西中医,2022,43(10):1337-1341.
[3] Malik S,Suchal K,Khan SI,et al.Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways[J].Am J Physiol Renal Physiol,2017,313(2):414-422.
[4] 吴 翔,毛盛程,陈 浪.血清长链非编码RNA Rpph1表达对2型糖尿病患者蛋白尿进展的预测价值研究[J].中国现代医学杂志,2022,32(3):16-20.
[5] 邵明玮,卫芳祎,宋 怡,等.长链非编码RNA在糖尿病肾病中的研究进展与展望[J].中华内分泌代谢杂志,2021,37(11):1020-1024.
[6] Yaribeygi H,Atkin SL,Sahebkar A.Interleukin-18 and diabetic nephropathy:A review[J].J Cell Physiol,2019,234(5):5674-5682.
[7] 袁凤英,孙少康,金智生.长非编码RNA NEAT1在糖尿病及其并发症中的分子调控机制[J].中国生物化学与分子生物学报,2022,38(2):159-164.
[8] Senthilkumar GP,Anithalekshmi MS,Yasir M,et al.Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy[J].Diabetes Metab Syndr,2018,12(1):23-26.
[9] Long J,Badal SS,Ye Z,et al.Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy[J].J Clin Invest,2016,126(11):4205-4218.
[10] Wang F,Gao X,Zhang R,et al.LncRNA TUG1 ameliorates diabetic nephropathy by inhibiting miR-21 to promote TIMP3-expression[J].Int J Clin Exp Pathol,2019,12(3):717-729.
[11] 李春梦,王海峰,卢 佩,等.糖尿病肾病患者D-二聚体、纤维蛋白原、胱抑素C检测及临床意义[J].陕西医学杂志,2020,49(11):1503-1506.
[12] Wang S,Yi P,Wang N,et al.LncRNA TUG1/miR-29c-3p/SIRT1 axis regulates endoplasmic reticulum stress-mediated renal epithelial cells injury in diabetic nephropathy model in vitro[J].PLoS One,2021,16(6):e0252761.
[13] 刘 芳,张立祥,王慧敏,等.养生益肾汤对糖尿病肾病患者血清细胞因子水平及肾功能的影响[J].陕西中医,2022,43(4):476-478.
[14] Yang H,Xie T,Li D,et al.Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway[J].Mol Metab,2019,23:24-36.
[15] 韩 敬,顾津伊,聂君旭,等.2型糖尿病肾病患者血清miR-27b-3p、miR-342-3p表达特点及临床意义[J].天津医药,2022,50(10):1077-1082.
[16] Lei X,Zhang L,Li Z,et al.Astragaloside Ⅳ/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats[J].Drug Des Devel Ther,2018,12:2785-2793.
[17] Chen Y,Li Z,Chen X,et al.Long non-coding RNAs:From disease code to drug role[J].Acta Pharm Sin B,2021,11(2):340-354.
[18] Xiang E,Han B,Zhang Q,et al.Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis[J].Stem Cell Res Ther,2020,11(1):336.
[19] 卢发菊,王 丽,陈永建.lncRNA TUG1靶向调控miR-199a-3p对高糖诱导的足细胞损伤的作用与机制研究[J].广西医科大学学报,2021,38(12):2294-2299.
[20] 李小丽,王 辉,张庆军.LncRNA TUG1靶向miR-222-3p对肺炎链球菌诱导的人肺泡上皮细胞损伤的影响[J].国际检验医学杂志,2021,42(24):3054-3058.
[21] 王 焕,尤冠巧,郭利芹,等.长链非编码RNA Gm15645对糖尿病肾病足细胞损伤的影响[J].中华医学遗传学杂志,2021,38(10):1017-1020.
[22] 俞元植,尹 敏,陈佳琦,等.circRNA在糖尿病肾病中的研究进展[J].中国实验诊断学,2022,26(10):1565-1569.
[23] Li L,Long J,Mise K,et al.PGC1α is required for the renoprotective effect of lncRNA Tug1 in vivo and links Tug1 with urea cycle metabolites[J].Cell Rep,2021,36(6):109510.
相似文献/References:
[1]袁江红.腹膜透析与血液透析治疗终末期糖尿病肾病患者疗效比较[J].陕西医学杂志,2016,(10):1365.
[2]徐 琳,贾睿博△,宋民喜,等.颗粒蛋白前体与糖尿病肾病关系探讨*[J].陕西医学杂志,2019,(8):1024.
[3]李 明,门 敏△,王丽萍,等.瑞舒伐他汀联合前列地尔治疗早期糖尿病肾病疗效研究*[J].陕西医学杂志,2019,(9):1223.
LI Ming,MEN Min,WANG Liping,et al.Efficacy of rosuvastatin combined with alprostadil in the 〖JZ〗treatment of early diabetic nephropathy[J].,2019,(3):1223.
[4]徐 琳,贺菲菲△.糖尿病肾病患者血清铁代谢指标与尿蛋白排泄量相关性分析*[J].陕西医学杂志,2019,(10):1281.
XU Ling,HE Feifei..Correlation between serum iron metabolism index and urine protein 〖JZ〗excretion in patients with diabetic nephropathy[J].,2019,(3):1281.
[5]高旭航,郑玉群,何志杰,等.基因多态性与糖尿病肾病关系研究进展[J].陕西医学杂志,2019,(11):1574.
GAO Xuhang,ZHENG Yuqun,HE Zhijie,et al.Research progress on relationsship between gene polymorphism and diabetic nephropathy[J].,2019,(3):1574.
[6]张晓丽.血液透析联合血液灌注对糖尿病肾病患者血清空腹血糖、
C反应蛋白、白细胞介素6影响的临床研究[J].陕西医学杂志,2020,49(1):68.
ZHANG Xiaoli..Effect of hemodialysis and blood perfusion on serum FPG,CRP and IL6 in patients with diabetic nephropathy[J].,2020,49(3):68.
[7]张 菁,姚 蔚,张进安,等.沙格列汀联合前列地尔治疗老年糖尿病肾病临床评价*[J].陕西医学杂志,2020,49(12):1657.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.032]
ZHANG Jing,YAO Wei,ZHANG Jin'an,et al.Clinical evaluation of saxagliptin combined with alprostadil in treatment of elderly diabetic nephropathy[J].,2020,49(3):1657.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.032]
[8]易亭伍,梁 睿,宿向东.长链非编码RNA SNHG15通过miR-141-3p /KLF9机制调控鼻咽癌细胞增殖的实验研究[J].陕西医学杂志,2021,50(1):10.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.003]
YI Tingwu,LIANG Rui,SU Xiangdong.Study on long chain non-coding RNA SNHG15 regulating the proliferation of nasopharyngeal carcinoma cells through miR-141-3p/KLF9[J].,2021,50(3):10.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.003]
[9]刘海波,许建秦,李春梦,等.胱抑素C和甘油三酯检测对糖尿病肾病的早期诊断价值研究[J].陕西医学杂志,2021,50(1):96.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.026]
LIU Haibo,XU Jianqin,LI Chunmeng,et al.Value of cystatin C and triglyceride in early diagnosis of diabetic nephropathy[J].,2021,50(3):96.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.026]
[10]袁 瑾,赵 灿,张渭涛.依普利酮通过靶向微小RNA-192和微小RNA-29a/b/c减轻糖尿病肾病模型大鼠肾损伤机制研究[J].陕西医学杂志,2022,51(3):293.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.007]
YUAN Jin,ZHAO Can,ZHANG Weitao.Mechanism of eplerenone alleviating renal injury in diabetic nephropathy rat model by targeting miR-192 and miR-29a/b/c[J].,2022,51(3):293.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.007]